Startup India Government of India
Ampligene Diagnostics Private Limited - healthcare in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹4.84 Lakh
▼ 81% YoY
Net profit · FY 2024
₹21,238
Net margin 4.4%
EBITDA · FY 2024
₹1.8 Lakh
EBITDA margin 37.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Brands
1
Associated brands
About Ampligene Diagnostics Private Limited
Data last updated:
Ampligene Diagnostics Private Limited is a private limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 14 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U93090GJ2018PTC105179.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deepal Pandya and Chirag Ramkrishna Pandya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F.F103 Ashwamegh Elegance – 2 Nr Chabada Building Nr Central Mall Ambawadi Circle, Ahmedabad, Gujarat, India – 380006.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.84 Lakh, a decline of 81% compared to the previous year. For the same year it recorded a net profit of ₹21,238 (net margin 4.4%) and EBITDA of ₹1.8 Lakh (EBITDA margin 37.3%). Revenue has declined at a compounded annual rate (CAGR) of 58% over three years and 16% over five years.
The company is associated with 1 brand: AmpliGene India Biotech.
For more details, the company can be reached via its website ampligeneindia.com.
Company details
CIN U93090GJ2018PTC105179
Registration Number 105179
Incorporation Date 14 November 2018
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Ampligene Diagnostics
Contact details
Ampligene Diagnostics Private Limited's registered office is in Ahmedabad, Gujarat. Its website is ampligeneindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressF.F103 Ashwamegh Elegance – 2 Nr Chabada Building Nr Central Mall Ambawadi Circle, Ahmedabad, Gujarat, India – 380006
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Ampligene Diagnostics Private Limited, buy the company report.
Comprehensive company report
Ampligene Diagnostics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Ampligene Diagnostics operates one associated brand: AmpliGene India Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Isothermal nucleic acid amplification systems are developed for pathogen detection. | ampligeneindia.com |
Business activity
The main business activity of Ampligene Diagnostics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Ampligene Diagnostics Private Limited, buy the company report.
Financials of Ampligene Diagnostics Private Limited
FY 2025 filings availableAmpligene Diagnostics Private Limited reported revenue of ₹4.84 Lakh (down 81% YoY) for FY 2024.
Revenue · FY 2024
₹4.84 Lakh ▼ 81%
Net profit · FY 2024
₹21,238 margin 4.4%
EBITDA · FY 2024
₹1.8 Lakh margin 37.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 81%
3 years · compounded
▼ 58%
5 years · compounded
▼ 16%
EBITDA CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 19%
5 years · compounded
▲ 40%
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 81% fall in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.8 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21,238 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 37.3% | ||||
| Net Profit Margin | 4.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ampligene Diagnostics Private Limited, buy the company report.
Board of directors of Ampligene Diagnostics Private Limited
Ampligene Diagnostics has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepal Pandya Also directs: Ampligene India Biotech Private Limited | Director | 01 Jun 2020 | 6 Years 4 Months | Current |
| Chirag Ramkrishna Pandya Also directs: Ampligene India Biotech Private Limited | Director | 14 Nov 2018 | 7 Years 11 Months | Current |
Peer comparison
Ampligene Diagnostics Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Barasat City Life Diagnostic Centre Private Limited | ₹5.09 Lakh (FY 2018) | -84.0% | Kolkata, West Bengal, India | |||
| Dr Reddys Pathlabs Private Limited | ₹4.85 Lakh (FY 2025) | -95.0% | Hyderabad, Telangana, India | |||
| Ampligene Diagnostics Private Limitedthis company | ₹4.84 Lakh (FY 2024) | ₹21,238 | 4.4% | -81.0% | Ahmedabad, Gujarat, India | |
| Glonutra Lifesciences Private Limited | ₹4.69 Lakh (FY 2019) | Bangalore, Karnataka, India |
To see the full peer comparison of Ampligene Diagnostics Private Limited, buy the company report.
Auditor
Ampligene Diagnostics Private Limited is audited by KEYUR BAVISHI & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KEYUR BAVISHI & CO | FY 2021 | 131191W |
Shareholding
The shareholding of Ampligene Diagnostics Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ampligene Diagnostics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ampligene Diagnostics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ampligene Diagnostics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ampligene Diagnostics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ampligene Diagnostics Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Deepal Pandya ceased to be Additional Director on 30 Dec 2020.
AGM
Ampligene Diagnostics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ampligene Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Deepal Pandya ceased to be Additional Director.
Ceased
Kuldip Mahesh Dangar ceased to be Director.
Appointed
Deepal Pandya was appointed as Director.
Ceased
Navdeep Mehta ceased to be Director.
Appointed
Chirag Ramkrishna Pandya was appointed as Director.
Incorporation
14 Nov 2018
Ampligene Diagnostics Private Limited was registered on 14 Nov 2018 with Roc Ahmedabad & aged 7 years 11 months as per MCA records.
Frequently asked questions
Ampligene Diagnostics is an active private limited company based in Ahmedabad, Gujarat, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 14 November 2018 (8+ years old) and is registered under CIN U93090GJ2018PTC105179.
Ampligene Diagnostics has 2 current directors:
- Deepal Pandya - Director
- Chirag Ramkrishna Pandya - Director
The latest financial statements of Ampligene Diagnostics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Ampligene Diagnostics is U93090GJ2018PTC105179. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ampligene Diagnostics was incorporated on 14 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Ampligene Diagnostics by revenue are Barasat City Life Diagnostic Centre Private Limited, Dr Reddys Pathlabs Private Limited, Glonutra Lifesciences Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).
Deepal Pandya ceased to be Additional Director on 30 Dec 2020. Kuldip Mahesh Dangar ceased to be Director on 15 Jun 2020. Deepal Pandya was appointed as Director on 01 Jun 2020. Ampligene Diagnostics has 5 board changes on record in total.
Yes, Ampligene Diagnostics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Ampligene Diagnostics can be reached through the website ampligeneindia.com. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Ampligene Diagnostics is at F.F103 Ashwamegh Elegance – 2 Nr Chabada Building Nr Central Mall Ambawadi Circle, Ahmedabad, Gujarat, India – 380006.
Ampligene Diagnostics operates in the healthcare industry, in the diagnostic centers and pathology labs segment.